Preliminary immunogenicity, safety, and efficacy of JNJ-64041757 (JNJ-757) in non-small cell lung cancer (NSCLC): Results from two phase 1 studies

This article has no abstract
Epistemonikos ID: a68fe7e40b405a12b5e6a5ad35b8bc7c321035d9
First added on: Feb 11, 2025